SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001192482-17-000226
Filing Date
2017-08-11
Accepted
2017-08-11 17:36:38
Documents
2
Period of Report
2017-08-09

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 3  
1 PRIMARY DOCUMENT edgar.xml 3 2298
2 POWER OF ATTORNEY poamelincoff.htm EX-24 2611
  Complete submission text file 0001192482-17-000226.txt   6392
Mailing Address 780 DEDHAM STREET, SUITE 800 CANTON MA 02021
Business Address 780 DEDHAM STREET, SUITE 800 CANTON MA 02021 781-713-3699
COLLEGIUM PHARMACEUTICAL, INC (Issuer) CIK: 0001267565 (see all company filings)

IRS No.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TOBIRA THERAPEUTICS, INC. 701 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address
Melincoff Gwen A (Reporting) CIK: 0001614890 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37372 | Film No.: 171026226